Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial

BACKGROUND: Screening for renal, hepatic and haematological disorders complicates the initiation of current first-line antiretroviral therapy (ART). Each additional test done adds substantial costs, both through direct laboratory expenses, but also by increasing the burden on health workers and pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Venter, Willem D. F., Majam, Mohammed, Akpomiemie, Godspower, Arulappan, Natasha, Moorhouse, Michelle, Mashabane, Nonkululeko, Chersich, Matthew F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498858/
https://www.ncbi.nlm.nih.gov/pubmed/28832288
http://dx.doi.org/10.1186/s12889-017-4353-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498858/
https://www.ncbi.nlm.nih.gov/pubmed/28832288
http://dx.doi.org/10.1186/s12889-017-4353-1

Ejemplares similares